A casual conversation between graduate students helped spark a breakthrough in aging research at Mayo Clinic. Researchers discovered that tiny synthetic DNA molecules called aptamers can selectively ...
Pulmatrix, Inc. ("Pulmatrix" or the "Company") , a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and ...
Announced merger agreement with Eos SENOLYTIX in March Closed private placement of preferred stock FRAMINGHAM, Mass., May 15, 2026 /PRNewswire/ -- Pulmatrix, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results